← FDA Drug Approvals (Drugs@FDA)
RASONQUE
NDA · New Drug Application · Sponsor: REVOLUTION MEDICINES · Approved 2026-08-26
Drug application
- FDA Application #
NDA220910- Application type
- New Drug Application
- Brand name
- RASONQUE
- Generic name
- DARAXONRASIB
- Active ingredients
- DARAXONRASIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- REVOLUTION MEDICINES
- Manufacturer
- Revolution Medicines, Inc.
- First approval
- 2026-08-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown